137 related articles for article (PubMed ID: 22528226)
1. Effect of Smac on TRAIL-induced apoptosis of prostate cancer cell line PC-3 and the molecular mechanism.
Wang M; Huang T; Zeng F; Jiang G; Wang L; Zheng L; Tong Q
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):233-236. PubMed ID: 22528226
[TBL] [Abstract][Full Text] [Related]
2. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Ng CP; Bonavida B
Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
[TBL] [Abstract][Full Text] [Related]
3. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
Dai Y; Liu M; Tang W; Li Y; Lian J; Lawrence TS; Xu L
BMC Cancer; 2009 Nov; 9():392. PubMed ID: 19895686
[TBL] [Abstract][Full Text] [Related]
4. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
5. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.
Fandy TE; Shankar S; Srivastava RK
Mol Cancer; 2008 Jun; 7():60. PubMed ID: 18590557
[TBL] [Abstract][Full Text] [Related]
6. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
[TBL] [Abstract][Full Text] [Related]
7. Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro.
Mao HL; Liu PS; Zheng JF; Zhang PH; Zhou LG; Xin G; Liu C
Pharmacol Res; 2007 Dec; 56(6):483-92. PubMed ID: 18029193
[TBL] [Abstract][Full Text] [Related]
8. [The cloning of human Smac gene and its pro-apoptotic effect on Burkitt's lymphoma cells].
Lu C; Wu SH; Chen JQ; Zhao F; Chi X; Pan XQ; Fei L; Guo M; Huang SM; Guo XR; Chen RH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):503-6. PubMed ID: 16083549
[TBL] [Abstract][Full Text] [Related]
9. Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicle.
Khorashadizadeh M; Soleimani M; Khanahmad H; Fallah A; Naderi M; Khorramizadeh M
Tumour Biol; 2015 Jun; 36(6):4213-21. PubMed ID: 25586349
[TBL] [Abstract][Full Text] [Related]
10. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis.
Guo F; Nimmanapalli R; Paranawithana S; Wittman S; Griffin D; Bali P; O'Bryan E; Fumero C; Wang HG; Bhalla K
Blood; 2002 May; 99(9):3419-26. PubMed ID: 11964312
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
[TBL] [Abstract][Full Text] [Related]
12. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
Ng CP; Zisman A; Bonavida B
Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis.
Zhao B; Li L; Cui K; Wang CL; Wang AL; Sun ZQ; Zhang B; Zhou WY; Niu ZX; Tian H; Xue Y; Li S
Asian Pac J Cancer Prev; 2011; 12(10):2675-8. PubMed ID: 22320973
[TBL] [Abstract][Full Text] [Related]
14. MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release.
Mohr A; Büneker C; Gough RP; Zwacka RM
Oncogene; 2008 Jan; 27(6):763-74. PubMed ID: 17653087
[TBL] [Abstract][Full Text] [Related]
15. General Sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC.
Quast SA; Berger A; Buttstädt N; Friebel K; Schönherr R; Eberle J
PLoS One; 2012; 7(6):e39290. PubMed ID: 22723988
[TBL] [Abstract][Full Text] [Related]
16. Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells.
Zheng LD; Tong QS; Wang L; Liu J; Qian W
World J Gastroenterol; 2005 Jan; 11(1):79-83. PubMed ID: 15609401
[TBL] [Abstract][Full Text] [Related]
17. Co-overexpression of TRAIL and Smac sensitizes MDA-MB-231 cells to radiation through apoptosis depending on mitochondrial pathway.
Xu W; Fang F; Wang Y; Qin L; Han Y; Huang Y; Li B; Liu Y; Wang Z
Radiat Environ Biophys; 2022 Mar; 61(1):37-48. PubMed ID: 35006369
[TBL] [Abstract][Full Text] [Related]
18. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X
Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766
[TBL] [Abstract][Full Text] [Related]
19. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
20. Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.
Servida F; Lecis D; Scavullo C; Drago C; Seneci P; Carlo-Stella C; Manzoni L; Polli E; Lambertenghi Deliliers G; Delia D; Onida F
Invest New Drugs; 2011 Dec; 29(6):1264-75. PubMed ID: 20614162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]